At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to reduce disparities and improve health equity, and more!

Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Evaluating Outpatient Teclistamab Administration in Multiple Myeloma: Robert Rifkin, MD

Oncology Data Advisor®